Robaxin and Xanthochromia - a phase IV clinical study of FDA data
We study 7,937 people who take Robaxin or have Xanthochromia. No report of Xanthochromia is found in people who take Robaxin.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
No report is found.
What is Robaxin?
Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 7,879 Robaxin users for its effectiveness, alternative drugs and more.
What is Xanthochromia?
Xanthochromia (yellowish appearance of cerebrospinal fluid) is found to be associated with 112 drugs and 64 conditions by eHealthMe.
Do you take Robaxin and have Xanthochromia?Check whether Xanthochromia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Robaxin:
- Robaxin (7,879 reports)
Xanthochromia treatments and more:
- Xanthochromia (58 reports)
COVID vaccines that are related to Xanthochromia:
- Xanthochromia in Moderna COVID Vaccine
- Xanthochromia in Pfizer BioNTech Covid Vaccine
- Xanthochromia in Johnson and Johnson Covid Vaccine
How severe was Xanthochromia and when was it recovered:
Expand to all the drugs that have ingredients of methocarbamol:
All the drugs that are associated with Xanthochromia:
All the conditions that are associated with Xanthochromia:
How the study uses the data?
The study uses data from the FDA. It is based on methocarbamol (the active ingredients of Robaxin) and Robaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ileitis Aggravated and Rhonchi - a second ago
- Dexamethasone and Heart Rate Irregular - 4 seconds ago
- Affect Lability and Ventricular Fibrillation - 6 seconds ago
- Spiriva and Tobrex drug interaction - 14 seconds ago
- Tenofovir Disoproxil Fumarate and Dacarbazine drug interaction - 16 seconds ago